12-Month mirror study on the effectiveness and safety of six-month paliperidone palmitate in patients with schizophrenia: A Multicenter Andalusian Cohort (PAPSEM study)
PP6M is an effective and well-tolerated option for patients with schizophrenia in real-world clinical practice. It reduces hospitalizations, improves clinical outcomes, and may contribute to decreased substance use.
Authors
- Luís Gutiérrez-Rojas (ORCID: https://orcid.org/0000-0003-0082-2189)
- Carlota Rodríguez
- R. G. Salas
- Jorge García-Jiménez (ORCID: https://orcid.org/0000-0002-3976-8776)
Institutions
- Universidad de Cádiz (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Gibraltar Health Authority (GI)
- Northeastern Mental Health Center (US)
- Hospital Universitario Virgen del Rocío (ES)
Publication Details
- Journal
- Psychiatry Research
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.psychres.2025.116903
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00